Sign in
Active, not recruitingNo phase

Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study

Key facts

Who runs it
Bluejay Diagnostics, Inc.
Where
Boston, Gainesville, Nashville, Salt Lake City, and Winston-Salem, United StatesSee the 5 sites
Trial code
Status
Active, not recruiting
People taking part
450 people, planned
Started
4 May 2026
Expected to end
30 Dec 2026
Type of study
Observational, 3 groups
Record updated
29 September 2026

Who can take part

Age
22 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 25 criteriaShow less

Who can take part

  • Adult patients (≥22 years of age)
  • Intent to admit to hospital or admitted to the hospital via the emergency department
  • At least 0.6 mL plasma drawn (optimal 1 mL) and available for collection (or is anticipated to be able to be drawn and available) within 12 hours of (i.e., up to 12 hours after) presentation to the emergency department. For Cohort 1, Criterion #1 criteria should be met within 3 hours of sample collection (fresh or remnant)
  • Meets criteria for at least one of the 3 cohorts (patients may be included in more than one cohort) within 12 hours of emergency department presentation:; Cohort 1 (Systemic inflammatory response or culture ordered):
  • Criterion #1 (2 of below within 3 hours of sample collection, of which 1 is at least (A) or (B))
  • A) body temperature >38C or <36C,
  • B) HR>90 beats/min,
  • C) respiratory rate >20 breaths/min, or
  • D) white blood cell count > 12K or <4K/microliters or over 10% immature forms or bands) OR:
  • Criterion #2 (order for culture of a body fluid (e.g., blood, urine, sputum)); Cohort 2 (Treatment for suspected infection initiated):
  • Meets criteria for Cohort 1 and antimicrobials (antibiotics or antivirals) ordered; Cohort 3 (Confirmed or strong evidence of infection):
  • Meets criteria for Cohorts 1 and 2, AND 1 or more of the following criteria:
  • Temp >101F (38.3C)
  • pneumonia by x-ray or CT,
  • Urinalysis with WBC>10/HPF
  • Intraabdominal-pelvis infection by CT, U/S, or MRI
  • Skin / soft tissue infection by clinical exam
  • Evidence of meningitis on LP
  • Positive microbiological culture (cultures drawn within 3 days of presentation)
  • Suspected line infection (e.g. redness or pus around the line)

Who cannot take part

  • Prior enrollment into this study
  • Prisoners or imprisonment at time of enrollment
  • Pregnant
  • Informed consent as approved by IRB is unable to be obtained
  • Environmental exposure (e.g., heat exposure)

Where in United States

  • Beth Israel Deaconess Medical CenterBoston, United States
  • University of Florida College of MedicineGainesville, United States
  • Vanderbilt University Medical CenterNashville, United States
  • Intermountain HealthSalt Lake City, United States
  • Wake Forest School of MedicineWinston-Salem, United States

About the trial

What the trial wants to find out

The primary objective of this study is to establish an IL-6 concentration cutoff that predicts sepsis or septic shock (according to the Third International Consensus Definitions (Sepsis-3 criteria)) in patients who are admitted or are intended to be admitted to the hospital from the emergency department with suspected infection.

The 3 groups in the trial

  • Cohort 1: Systemic inflammatory response or culture ordered

    Criterion #1: (2 of the following within 3 hours of sample collection, of which 1 is at least (A or B): A) body temp \>38c or \<36c B) HR \>90bpm C) respiratory rate \>20 breaths/min D) white blood cell count \>12k or \<4k/microliters or over 10% immature forms or bands, OR Criterion #2: order for culture of a body fluid (blood, urine, sputum)

  • Cohort 2: Treatment for suspected infection initiated

    Meets criteria for Cohort 1 and antimicrobials (antibiotics or antivirals) ordered

  • Cohort 3: Confirmed or strong evidence of infection

    Meets criteria for Cohorts 1 and 2, AND 1 or more of the following criteria: Temp \>101F (38.3c) Pneumonia by X-ray or CT Urinalysis with WBC \>10/HPF Intraabdominal-pelvis infection by CT U/S or MRI Skin/soft tissue infection by clinical exam Evidence of meningitis on LP Positive microbiological culture (cultures drawn within 3 days of presentation) Suspected line infection (e.g., redness or pus around the line)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
29 September 2026